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Wednesday, February 24, 2010 685abiosensor system with defined physicochemical properties is needed. One
promising approach is the immobilization of MRP-containing proteolipo-
somes on functionalized surfaces. We report a new system for immobilizing
biotin-doped proteoliposomes via the well-known biotin-streptavidin interac-
tion on gold surfaces functionalized with a self assembled monolayer (SAM)
of a binary thiol mixture. The SAM composed of a hydroxy-terminated 16-
carbon alkanethiol and its biotinylated derivative protects the gold surfaces
from unspecific adsorption and allows the immobilization of defined quanti-
ties of streptavidin. Proteoliposomes made from natural lipid compositions
and doped with a biotinylated anchor lipid can readily be tethered to these
surfaces. By thorough biophysical characterization using quartz crystal mi-
crobalance (QCM), atomic force microscopy (AFM) and fluorescence tech-
niques all experimental parameters were optimized for application in biosen-
sor systems. We successfully immobilized intact proteoliposomes containing
the reconstituted human ABC transporter MRP3 on the described surfaces.
Our system allows the investigation of ABC transporters by a variety of sur-
face-enhanced techniques ranging from AFM and QCM to impedance spec-
troscopy and surface plasmon resonance based methods under well-defined
conditions closely mimicking the protein’s natural environment.
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Functionally Rotating Mechanism of a Multidrug Transporter Studied by
Coarse-Grained Simulation
Xin-Qiu Yao1, Hiroo Kenzaki1, Shoji Takada1,2.
1Kyoto University, Kyoto, Japan, 2CREST, Japan Science and Technology
Agency, Tokyo, Japan.
The existence of multidrug transporters accounts for the multidrug resistance of
bacteria encountered in the treatment of many infectious diseases. The recently
solved crystal structure of AcrB, a major multidrug exporter in Escherichia coli,
suggests a functionally rotating mechanism for such an efflux system [1]. Ac-
cording to this mechanism, each protomer of the trimer stays in one of the three
states in an asymmetric way, and exclusively binds and extrudes drugs by ac-
cessing ‘‘Binding’’ state sequentially. To testify such a hypothesis, we have
performed molecular dynamics simulation of the ‘‘porter’’ domain of AcrB
around native state. The system was coarse-grained by using one bead posi-
tioned on Ca atom to represent each residue, and the energy function was de-
scribed by the multiple-basin model [2]. In this work we realized, for the first
time, triple-basin energy landscape for each protomer, by which frequent con-
formational change was simulated. Using this model, we calculated the config-
uration distribution of the trimer in equilibrium based on various energy land-
scapes, and the obtained phase diagram could be used to elucidate the
mechanism of protein function. Further investigation includes the consideration
of an explicit ligand bound in the ‘‘binding’’ protomer by hydrophobic interac-
tion, and the direct simulation of functional rotation and exportation of ligand,
details of which will be presented on the meeting.
Key words: AcrB, multi-basin model, re-weighting
[1] Murakami, S. et al., (2006) Nature 443, 173-9.
[2] Okazaki, K. et al., (2006) Proc Natl Acad Sci U S A 103, 11844-9.
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Multidrug efflux transporters cause for antimicrobial resistance in the chemo-
therapy of cancer and antibiotic treatment of numerous different bacterial infec-
tions. In E. coli, it is known that the tripartite multidrug efflux system (AcrB/
AcrA/ TolC) exists, and AcrB resides in the inner membrane region and take
part in substrate recognition and energy transduction for drug export through
proton transfer. Recently, x-ray structures provided that AcrB forms trimeric
protein where each subunit is different conformation, ‘‘binding state’’, ‘‘extru-
sion state’’ and ‘‘access state’’. These results suggest that drugs are exported by
a three-step structural change. In the present study, we performed a series of all-
atom molecular dynamics (MD) simulations of AcrB-membrane-water system
and analyzed the structural change mechanism among three subunits.
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Alana A. White, J.B. Alexander Ross, Erica L. Woodahl.
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P-glycoprotein (P-gp) is an efflux drug transporter and member of the ATP-
binding cassette (ABC) superfamily, encoded by the ABCB1 (MDR1) gene.
P-gp is located in tissues important in drug disposition, including intestine,
liver, kidney, and blood-brain barrier. Due to its wide tissue distribution andbroad substrate specificity, P-gp is important in drug disposition. P-gp is known
to transport a wide variety of structurally and functionally different drugs, but
the mechanism for binding and transport is poorly understood. The ABCB1
gene is polymorphic and single nucleotide polymorphisms (SNPs) are known
to alter transport via mechanisms that are unclear. Our goal is to utilize bio-
physical and computational methods to understand structure-function relation-
ships in ABCB1 wild-type and its variants. We have built a wild-type human P-
gp homology model based on the recently published mouse crystal structure
(Aller et al., Nature, 2009), and homology models for ABCB1 SNPs
1199G>A (S400N), 1199G>T (S400I), 2677G>T (A893S), 2677G>A
(A893T), and 2677G>C (A893P) using SYBYL8.0 software. Our model pre-
dicts that human P-gp has 12 transmembrane helices and an overall prolate
shape, ~150x60A˚, with a depth of ~60A˚ perpendicular to, ~40A˚within, ~30A˚
above, and ~80A˚ below the membrane. The two intracellular nucleotide-bind-
ing domains are separated by ~20A˚ in the nucleotide-free state and move into
contact in the nucleotide-bound state. We demonstrated that polymorphisms al-
ter the secondary structure of P-gp. We have also modeled the hypothesized
ATP-switch mechanism for P-gp transport and developed a visualization of
this movement. We plan to incorporate wild-type and variant P-gp into lipid-
based nanodiscs to study differential substrate binding and changes in confor-
mation using single-molecule fluorescence. We will correlate these results, and
those from in vitro transport studies, with pharmacophore modeling and QSAR
studies to further understand the functional significance of genetic variation in
ABCB1.
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Bacteria, such as E. coli, use multidrug efflux pumps to export toxic substrates
through their cell membranes, including antibiotics. The RND transporter of
the AcrAB-TolC efflux pump is able to export structurally and chemically dif-
ferent substrates via a functional rotation. The three major states of this rotation
cycle were found in several asymmetric crystal structures. After initially ana-
lyzing the basic mechanisms of opening of the TolC channel [1] and of sub-
strate extrusion by AcrB [2] separately, we have continued the analysis of
the latter one. Thereby, we have focused both on the local interactions between
substrate and protein, the properties of the extrusion pathway, as well as the
principal subdomain movements which lead to the peristaltic motion. Further-
more, we have investigated the possibility to pull the substrate from the final
state of the previous simulations out of the exit gate to estimate whether the
substrate is already free to leave the protein via diffusion, which is usually be-
yond the time scale of computer simulations.
[1] R. Schulz, U. Kleinekatho¨fer, Biophys. J. 96, 3116 (2009)
[2] R. Schulz, A. Vargiu, F. Collu, U. Kleinekatho¨fer, P. Ruggerone, submitted
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In order to directly observe conformational change in the mitochondrial citrate
transport protein (CTP), we measured, in the presence and absence of inhibi-
tors, the EPR spectra of spin-labeled single-Cys CTP mutants that were recon-
stituted in liposomes. We selected spin-label locations to report on substrate
binding sites 1 and 2 (i.e., 187, 183, and 179), binding site 2 (39), TMDIII
pointing away from the transport pathway (118), and a matrix-facing hydro-
philic loop (47). In the absence of inhibitor, the EPR lineshapes show resi-
due-dependent variations in mobility. Addition of external 1,2,3-benzenetricar-
boxylate (BTC), the defining inhibitor of the CTP, caused a modest, residue-
dependent decrease in the mobile component and a concomitant increase in
the immobile component. Addition of compound 792949, a novel, purely com-
petitive inhibitor that we previously identified via high throughput in silico
screening using the homology-modeled CTP in its cytosolic-facing conforma-
tion, yielded EPR spectra that contain a substantial increase in the immobile
component at each location. We conclude that the two inhibitors cause CTP
to assume different conformations, which vary significantly in their extent of
immobilization.
686a Wednesday, February 24, 2010Surprisingly, in contrast to the large immobilizing effect observed upon the ad-
dition of extraliposomal inhibitor 792949, the inclusion of intraliposomal in-
hibitor caused only a minor spectral change. This observation indicates that
binding of 792949 to CTP from the internal surface of the proteoliposomes
(i.e., the matrix-facing conformation) occurs to a much lesser extent than
does binding to CTP from the external surface (i.e., the cytosolic-facing confor-
mation). We conclude that external 792949 affects spin-label mobility at both
monomers within the functional homodimer suggesting a tight coordination of
the two monomers. Supported by NIH grant GM-054642 to R.S.K.
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Excitatory amino acid transporters (EAATs) remove glutamate from the synap-
tic cleft to ensure low resting glutamate concentrations and to terminate gluta-
matergic synaptic transmission. We here study substrate binding to a bacterial
EAAT paralog with known structure, GltPh from Pyrococcus horikoshii, using
fluorescence spectroscopy. We expressed mutant transporter with an inserted
tryptophan in the TM3-TM4-linker, L130W GltPh, and studied tryptophan fluo-
rescence of solubilized and purified L130W GltPh. In the presence of Na
þ, ad-
dition of aspartate causes changes in fluorescence intensities, as does addition
of Naþ in the presence of aspartate, allowing the construction of aspartate and
Naþ binding isotherms. Titrations of the mutant protein with aspartate at in-
creasing temperatures resulted in increased apparent dissociation constants.
Van’t Hoff plots were linear over a measured range from 10 to 40C, yielding
a large negative aspartate binding enthalpy that is partly compensated by a neg-
ative binding entropy. Naþ binding equilibria were less temperature dependent,
but Naþ binding showed to be enthalpy driven as well. Pre-equilibrium kinetics
of substrate binding were monitored by measuring fluorescent changes after
rapid application of substrates to L130W GltPh. Exponential fits to the binding
transients required two time constants t1 and t2, reflecting at least two under-
lying processes. Most of the change in fluorescence was associated with the fast
process with t1 in the range of hundreds of ms. t1
1 showed linear dependence
on [Naþ], suggesting that the fast process represents Naþ binding. Aspartate
uptake by GltPh was recently shown to exhibit a Q10 of 3.7, indicating at least
one significant conformational change during the transport cycle (Ryan et al.
(2009) J Biol Chem 284, 17540-17548.). t1 was decreased by rising tempera-
tures, but with lower Q10 than the whole transport cycle.
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Glutamate acts as the primary excitatory neurotransmitter in the mammalian
central nervous system. Clearance of this neurotransmitter from the synapse
is accomplished by a family of glutamate transporters known as EAATs, which
move synaptic glutamate across the cell membrane into the cell against its con-
centration gradient. It has long been speculated that the mechanism for transport
involves the movement of extracellular and intracellular gates, providing ‘‘al-
ternating access’’ to a substrate binding site. Recently, the crystal structure of
a related bacterial transporter, GltPh, was solved, revealing two helical hairpins
(HP1 and HP2) which have been proposed to contribute to these gates. A num-
ber of studies have shown that HP2, which lies on the extracellular side of the
protein, can adopt multiple conformations that either provide or restrict access
to the substrate binding site. However, to date there is no structural information
describing conformational changes involving HP1. Here we use the technique
of site-directed spin labeling (SDSL) electron paramagnetic resonance (EPR)
spectroscopy to explore the local structure and dynamics of residues within
HP1 (residues 264-283) in purified GltPh reconstituted into proteoliposomes.
The EPR spectra suggest that the protein exists in two conformational states un-
der our purification conditions. Upon addition of substrate, we note changes in
the relative abundance of these states. We are currently working to further char-
acterize each of these conformational states in order to better understand the
structural dynamics associated with substrate transport.
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Forward glutamate transport by the excitatory amino acid carrier EAAC1 is
coupled to the inward movement of three Naþ and one Hþ, and the outwardmovement of one Kþ ion. Internal Kþ is known to bind to the transporter after
glutamate and Naþ are unloaded to the cytosol, subsequently initiating reloca-
tion of the transporter binding sites to complete the transport cycle. However,
parameters of Kþ interaction with EAAC1, such as affinity and voltage depen-
dence, are currently unknown. Here, we determined the steady-state and pre-
steady state kinetics of the interaction of Kþ with its extracellular binding
site, and the subsequent Kþ transport step, by using transport current recording
from EAAC1-transfected cells. Our results show that Kþ binds to its extracel-
lular binding site with high affinity (Km ¼ 4.5 mM). Kþ affinity is only weakly
voltage dependent. However, transient transport currents were observed in re-
sponse to steps of the transmembrane potential when Kþ was the only cation
present. These currents were capacitive in nature and the charge movement fol-
lowed a Boltzmann-like voltage dependence. Together, these results suggest
that the cation binding process senses little of the transmembrane electric field,
but that a subsequent Kþ-induced reaction step, possibly the Kþ-dependent
transporter relocation, is electrogenic. The rate constant of the voltage depen-
dent step was 70 s1. This result is consistent with previous data that suggested
the Kþ-induced relocation to be the rate-limiting step in the transport cycle. We
propose a kinetic model, which is based on an alternating access mechanism,
including a fast, voltage-independent Kþ binding step and a slow, electrogenic
conformational change. Our model can be used to predict the kinetics of the
Kþ-dependent half-cycle of the glutamate transport process.
This work was supported by NIH grant 2R01NS049335-06A1.
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The crystal structure of GltPh, a bacterial homologue of glutamate transporter
(GlT), revealed the structure of the outward-facing occluded state including the
substrate and two Naþ (Na1 and Na2). It has been well established, however,
that substrate transport in GltPh is catalyzed by the co-transport of three Naþ
ions. However, the location of the third Naþ (Na3) binding site remains un-
known. Furthermore, only little is known regarding the sequence of binding
events of the substrate and the co-transported ions to GltPh. In the present
study, we investigate the binding sequence of substrate and Naþ ions to their
extracellular binding sites using molecular dynamics simulations of various
bound states of the transporter characterizing the solvent accessibility of key
residues involved in ion binding and identifying the resulting conformational
changes in the transporter. The results show that extracellular water cannot ac-
cess Asp312 (the putative Na3 binding site) in the apo and substrate-bound
states, and that this residue becomes only accessible from the extracellular
side upon Naþ binding to the Na1 binding site. Based on the simulations,
we propose that Na3 binds first to the Na1 binding site in the apo state, resulting
in hydration of Asp312, and then moves into the Na3 binding site, the latter step
likely being driven by membrane potential. The subsequent binding of a second
Naþ ion (Na1) and the substrate results in a partial closure of the extracellular
gate and the formation of the Na2 binding site. Finally, Na2 enters its binding
site and locks the extracellular gate resulting in formation of the occluded state.
We also propose a putative Na3 binding site composed of three highly con-
served residues, namely, Asp312, Thr92 and Asn310.
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The crystal structure of Naþ-coupled galactose symporter (vSGLT) reports the
transporter in its substrate-bound state, with a Naþ ion modeled in a binding site
corresponding to that of a homologous protein, leucine transporter (LeuT). In
molecular dynamics simulations, however, we find the Naþ ion instable, invari-
ably and spontaneously diffusing out of the transporter through a pathway lined
by D189, which appears to facilitate the diffusion of the ion toward the cyto-
plasm. Further analysis of the trajectories and close structural examination,
in particular comparison of the Naþ binding sites of vSGLT and LeuT, strongly
indicates that the crystal structure of vSGLT actually represents an ion-releas-
ing state of the transporter. The observed dynamics of the Naþ ion, in contrast
to the substrate, in a 200 ns equilibrium simulation, also suggests that the cy-
toplasmic release of the Naþ ion precedes that of the substrate.
Through comparison of the ‘‘open’’ conformation of the Naþ binding site in
vSGLT and the ‘‘close’’ conformation in LeuT, we used constrained simula-
tion to develop a model for the ion-binding state in vSGLT. SMD simulations
were then used to pull out substrate from the substrate-binding site both in
